Welcome to the CRL Insurer Services blog! Here you will find commentary from our dedicated team of medical directors and industry leaders on lab research and trends, innovative services and solutions, and what’s new at CRL. Click the button below to get the latest news directly to your inbox. Questions? Contact us at ILSsales@crlcorp.com.
Dr. Michael Fulks, Consulting Medical Director, discusses recent articles on several new obesity drugs that are hoped to be cheaper… Read More
Tags: Diabetes, Life Insurance, Mortality, Obesity, Weight loss
Dr. Michael Fulks, Consulting Medical Director, highlights two recent studies showing the range of conditions potentially treatable by a single… Read More
Tags: Cardiovascular Disease, Hypertension, Life Insurance, Risk, siRNAs
Dr. Michael Fulks, Consulting Medical Director, discusses the latest results for the use of lecanemab in early Alzheimer’s disease. Beta… Read More
Tags: Alzheimers, Dementia, Lecanemab, Life Insurance
Dr. Michael Fulks, Consulting Medical Director, highlights a report discussing how the prevalence of dementia has declined in the United… Read More
Tags: Alzheimers, Cardiovascular risk, Dementia, Life Insurance, Underwriting
Dr. Michael Fulks, Consulting Medical Director, discusses current research on triglyceride levels and their impact on cardiovascular mortality risk. Way… Read More
Tags: Cholesterol, Life Insurance, Mortality, Triglycerides, Underwriting
Dr. Steven Rigatti, Consulting Medical Director to CRL, comments on a study showing how death rates caused by falls have… Read More
Tags: Deaths by falls, Life Insurance, Mortality, Underwriting
Dr. Michael Fulks, Consulting Medical Director, highlights a report discussing the prevalence and recommendation for annual screening of heart failure… Read More
Tags: Diabetes, Heart failure, Life Insurance, Mortality, Underwriting
Dr. Michael Fulks, Consulting Medical Director, details a new study showcasing the increase in mortality rates from drug and alcohol… Read More
Tags: Alcohol usage, Drug usage, Life expectancy, Life Insurance, Mortality, Overdose
With the approval of new drugs by Eisai and Biogen, genetic testing for Alzheimer’s is on the rise. This article… Read More
Tags: Alzheimers, Genetic Testing, Life Insurance, Underwriting
Michael Fulks, MD, comments on recent research in the Journal of the American College of Cardiology. Dr. Fulks reviews the… Read More
Tags: Coronary heart disease, HDL, Life Insurance, Mortality, Research